Roche Holding AG

RHHBY

40.22

USD

+0.04

(+0.10%)

Day's range

40.11

40.55

52 wk Range

33.76

44.31

General Financials Dividends Technical

Key Statistics

Previous Close

40.18

Open

40.55

Day's Range

40.11 - 40.55

52 wk Range

33.76 - 44.31

Volume

10.50K

Average Volume

2.32M

Market Cap

260.19B

Shares Outstanding

6.47B

Revenue

62.40B

Net Income

8.28B

EPS

1.57

P/E Value

25.62

Next Earnings Date

Jul 24, 2025

Dividend (Yield)

3.70%

Return on Assets

8.13%

Return on Equity

27.27%

Gross Profit Margin

74.07%

Price/Book

6.56

EBITDA

16.62B

EV/EBITDA (TTM)

14.59

P/BV Value

6.56

P/S Value

3.44

Beta

0.172

Roche Holding AG Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Industry

Drug Manufacturers - General

Sector

Healthcare

Employes

103249

Market

Site

https://roche.com